Feasibility and efficacy of cyberknife radiotherapy for lung cancer: Early results;Analyse de la toxicité précoce des traitements par Cyberknife® des cancers pulmonaires et résultats préliminaires

Cancer/Radiotherapie

Volumn 12, Issue 8, 2008, Pages 793-799

  Castelli, J ^a   Thariat, J ^a   Benezery, K ^a   Padovani, B ^b   Ducreux, D ^b   Venissac, N ^b   Poudenx, M ^a   Otto, J ^a   Mouroux, J ^b   Bondiau, P Y ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b PASTEUR HOSPITAL   (France)

Author keywords

Control rate; Cyberknife ; Fiducials; Lung cancer; Response; Stereotactic radiotherapy; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; ASTHENIA; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COLORECTAL DISEASE; COLORECTAL METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYBERKNIFE; FEASIBILITY STUDY; FRANCE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; PNEUMOTHORAX; PRIORITY JOURNAL; RELIABILITY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; ROBOTICS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 57249097219     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2008.06.002     Document Type: Article

References (37)

1. Adler Jr. J.R. Surgical guidance now and in the future: the next generation of instrumentation. Clin Neurosurg 49 (2002) 105
2. Blomgren H., Lax I., Naslund I., and Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34 (1995) 861
3. ® robotic stereotactic radiotherapy: technical aspects and medical indications. Cancer Radiother 11 (2007) 338
4. Bradley J., Graham M.V., Winter K., Purdy J.A., Komaki R., Roa W.H., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318
5. Brown W.T., Wu X., Amendola B., Perman M., Han H., Fayad F., et al. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife. Cancer J 13 (2007) 87
6. Brown W.T., Wu X., Fayad F., Fowler J.F., Amendola B.E., Garcia S., et al. CyberKnife radiosurgery for stage I lung cancer: results at 36 months. Clin Lung Cancer 8 (2007) 488
7. Cheung P.C., Yeung L.T., Basrur V., Ung Y.C., Balogh J., and Danjoux C.E. Accelerated hypofractionation for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1014
8. Collins B.T., Erickson K., Reichner C.A., Collins S.P., Gagnon G.J., Dieterich S., et al. Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors. Radiat Oncol 2 (2007) 39
9. Drings P. IALT Trial. Internist (Berl) 46 (2005) 214
10. Ekberg L., Holmberg O., Wittgren L., Bjelkengren G., and Landberg T. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?. Radiother Oncol 48 (1998) 71
11. Feuvret L., Noel G., Nauraye C., Garcia P., and Mazeron J.J. Index de conformation et radiotherapie. Cancer Radiother 8 (2004) 108
12. Fletcher G.H. Clinical dose-response curve of subclinical aggregates of epithelial cells. J Radiol Electrol Med Nucl 53 (1972) 201
13. ® Lung Tracking System: A fiducial-less method for respiratory motion tracking, in treating tumors that move with respiration. 2007. p. 265.
14. Fu, D., G. Kuduvalli, Enhancing skeletal features in digitally reconstructed radiographs. In: Medical Imaging 2006: Image Processing. 2006. San Diego, CA, USA: SPIE (Online sur http://spiedl.aip.org/getabs/servlet/GetabsServlet) (visité le 31/05/2007).
15. Giraud P., Antoine M., Larrouy A., Milleron B., Callard P., De Rycke Y., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48 (2000) 1015
16. Giraud P., Yorke E., Jiang S., Simon L., Rosenzweig K., and Mageras G. Reduction of organ motion effects in IMRT and conformal 3D radiation delivery by using gating and tracking techniques. Cancer Radiother 10 (2006) 269
17. Hannoun-Levi J.M., Benezery K., Bondiau P.Y., Chamorey E., Marcie S., and Gerard J.P. Robotic radiotherapy for prostate cancer with CyberKnife. Cancer Radiother 11 (2007) 476
18. HAS, Radiothérapie extracrânienne en condition stéréotaxique. www.hassante.fr, 2006 (Visité le 31/05/2007).
19. Le Q.T., Loo B.W., Ho A., Cotrutz C., Koong A.C., Wakelee H., et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 1 (2006) 802
20. Mageras G.S., Yorke E., Rosenzweig K., Braban L., Keatley E., Ford E., et al. Fluoroscopic evaluation of diaphragmatic motion reduction with a respiratory gated radiotherapy system. J Appl Clin Med Phys 2 (2001) 191
21. Nagata Y., Takayama K., Matsuo Y., Norihisa Y., Mizowaki T., Sakamoto T., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427
22. ®: Marker placement and early results. Acta Oncol 45 (2006) 961
23. Onishi H., Araki T., Shirato H., Nagata Y., Hiraoka M., Gomi K., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623
24. Papiez L., Timmerman R., DesRosiers C., and Randall M. Extracranial stereotactic radioablation: physical principles. Acta Oncol 42 (2003) 882
25. Pennathur A., Luketich J.D., Burton S., Abbas G., Heron D.E., Fernando H.C., et al. Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience. Ann Thorac Surg 83 (2007) 1820
26. Perez C.A., Bauer M., Edelstein S., Gillespie B.W., and Birch R. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 539
27. Perez C.A., Stanley K., Rubin P., Kramer S., Brady L., Perez-Tamayo R., et al., Preliminary report by the Radiation Therapy Oncology Group. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Cancer 45 (1980) 2744
28. Rosenzweig K.E., Fox J.L., Yorke E., Amols H., Jackson A., Rusch V., et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 103 (2005) 2118
29. Saji H., Nakamura H., Tsuchida T., Tsuboi M., Kawate N., Konaka C., et al. The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy: the angle of the needle trajectory is a novel predictor. Chest 121 (2002) 1521
30. Sause W., Kolesar P., Taylor S.I., Johnson D., Livingston R., Komaki R., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117 (2000) 358
31. Simon L., Giraud P., Dumas J.L., Marre D., Dupont S., Varmenot N., et al. Practical recommendations for breathing-adapted radiotherapy. Cancer Radiother 11 (2007) 214
32. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205
33. Timmerman R., Papiez L., McGarry R., Likes L., DesRosiers C., Frost S., et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946
34. Whyte R.I., Crownover R., Murphy M.J., Martin D.P., Rice T.W., DeCamp Jr. M.M., et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg 75 (2003) 1097
35. Wu, X., D. Fu, A. Zerda, E. Bossart, H. Shao, J. Both, et al., Patient Alignment and Target Tracking in Radiosurgery of Soft-Tissue Tumors Using Combined Fiducial and Skeletal Structures Tracking Techniques, in Treating Tumors that Move with Respiration. Berlin; Springer: 2007. p. 31.
36. Wulf J., Baier K., Mueller G., and Flentje M.P. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83
37. Wulf J., Hadinger U., Oppitz U., Thiele W., Ness-Dourdoumas R., and Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 (2001) 645